(Q36206071)

English

Chromatin modifications as targets for new anticancer drugs

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

title

Chromatin modifications as targets for new anticancer drugs (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12 August 2017

Stefan Schäfer

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16041839

retrieved

12 August 2017

Manfred Jung

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16041839

retrieved

12 August 2017

publication date

1 August 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16041839

retrieved

12 August 2017

published in

Archiv der Pharmazie - Chemistry in Life Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16041839

retrieved

12 August 2017

volume

338

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16041839

retrieved

12 August 2017

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16041839

retrieved

12 August 2017

page(s)

347-357

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16041839

retrieved

12 August 2017

cites work

Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FARDP.200500984

retrieved

21 January 2018

Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformation activities as antitumor agents.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.43.1524

Identifiers

DOI

10.1002/ARDP.200500984

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16041839

retrieved

12 August 2017

PubMed publication ID

16041839

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16041839

retrieved

12 August 2017

(Q36206071)

Chromatin modifications as targets for new anticancer drugs

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)